Literature DB >> 11002935

Idiopathic or mesothelioma-related pericardial effusion: clinical findings and survival in 17 dogs studied retrospectively.

R L Stepien1, N T Whitley, R R Dubielzig.   

Abstract

This retrospective study compares the clinical signs and diagnostic findings of 17 canine patients with histopathological diagnoses of idiopathic pericardial effusion (IPE) or pericardial mesothelioma (MS) in order to identify differences in clinical findings or survival times that might aid in premortem differentiation of these disease conditions. Based on this series of cases, clinical signs, physical examination findings and results of non-invasive diagnostic testing are insufficient to differentiate MS from IPE with confidence unless a discrete pericardial or intrapericardial mass can be identified. Surgical biopsy may be misleading if large amounts of highly reactive and invasive mesothelial cells are seen. Recurrence of significant amounts of pleural effusion within 120 days of pericardiectomy may increase the likelihood that MS is the cause of pericardial effusion in cases in which other causes have been excluded. Survival longer than 120 days postpericardiectomy without chemotherapeutic intervention is associated with a decreased probability of the condition being MS.

Entities:  

Mesh:

Year:  2000        PMID: 11002935     DOI: 10.1111/j.1748-5827.2000.tb03215.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  3 in total

1.  Presumptive seeding metastasis of pericardial mesothelioma following repeated pericardiocentesis in a dog.

Authors:  Keaton R S Morgan; Christopher G Dominic; Janet Beeler-Marfisi; Karlee Craig; Katie L Hoddinott; Siobhan O'Sullivan; Ameet Singh
Journal:  Can Vet J       Date:  2019-09       Impact factor: 1.008

2.  Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations.

Authors:  Enrico P Spugnini; Stefania Crispi; Alessandra Scarabello; Giovanni Caruso; Gennaro Citro; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2008-05-19

3.  Analytical validation of the Sysmex XT-2000iV for cell counts in canine and feline effusions and concordance with cytologic diagnosis.

Authors:  Nazaré Pinto da Cunha; Alessia Giordano; Mario Caniatti; Saverio Paltrinieri
Journal:  Vet Clin Pathol       Date:  2009-02-02       Impact factor: 1.180

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.